Thursday, February 27, 2020

Moderna (MRNA) Stock Soars Over 20% on Coronavirus Vaccine

Moderna (NASDAQ: MRNA), a US biotechnology company, launched an experimental coronavirus vaccine for US government researchers only six weeks after


from
https://alphabetastock.com/2020/02/27/mrna-stock-soars-over-20-on-coronavirus-vaccine/

No comments:

Post a Comment